Lupin bags tentative USFDA nod for HIV-1 infection drugs Ruchika Sharma31 July 2024 12:30 PM ISTMumbai: Global pharma major Lupin Limited today announced that it has received tentative approval from the United States Food and Drug...
USFDA approves Biktarvy label update with data for pregnant adults with HIV: Gilead Sciences Ruchika Sharma28 April 2024 11:30 AM ISTFoster City: Gilead Sciences, Inc. has announced the U.S. Food and Drug Administration (FDA) has approved an updated label with additional data...
USFDA approves Gilead Sciences Vemlidy sNDA for chronic hepatitis B virus infection in pediatric patients as young as Six Ruchika Sharma30 March 2024 4:15 PM ISTFoster City: Gilead Sciences, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug...
Expanded Indication for Gilead Biktarvy for HIV with suppressed viral loads, pre-existing resistance gets USFDA okay Ruchika Sharma27 Feb 2024 12:30 PM ISTFoster City: Gilead Sciences, Inc. has announced the U.S. Food and Drug Administration (FDA) has approved a new, expanded indication for Biktarvy...
Gilead partners with CHAI, Penta to improve treatment, adherence rates among children with HIV in low, middle income countries Ruchika Sharma16 July 2023 10:00 AM ISTFoster City: Gilead Sciences, Inc. has announced two public-private partnerships. The first will accelerate the development of an investigational...
Emcure Pharmaceuticals Gets CDSCO To Manufacture & Market the FDC Antiviral Drug Dr. Divya Colin4 May 2023 6:00 PM ISTNew Delhi: Granting approval for bioequivalence (BE) study and clinical trial (CT) study waiver, the Subject Expert Committee (SEC) functional under...
Lupin bags tentative USFDA nod for Dolutegravir, Emtricitabine and Tenofovir Alafenamide Tablets to control HIV infections Ruchika Sharma31 Jan 2023 3:30 PM ISTMumbai: Global pharma major Lupin Limited today announced that it has received tentative approval from the United States Food and Drug...
